Sandra Black, MD, FRCP(C) is an internationally renowned cognitive and stroke neurologist who holds the inaugural Brill Chair in Neurology, Department of Medicine, University of Toronto and Sunnybrook Health Sciences Centre. A leading clinical trialist in dementia, she is the current Executive Director of the Toronto Dementia Research Alliance, a multi institutional collaborative network of memory programs at the University of Toronto involving Baycrest, Centre for Addiction and Mental Health, St. Michael’s Hospital, Sunnybrook HSC and Toronto Western Hospital, UHN. She is also the Sunnybrook Site Director of the Heart & Stroke Foundation Canadian Partnership for Stroke Recovery and the Hurvitz Brain Sciences Research Program Director at Sunnybrook Research Institute. In 2011 she was named to the Order of Ontario, cited as an assiduous physician leader and influential architect of the Ontario Stroke System. She has authored/co-authored over 450 papers in a 25-year research career that has bridged dementia and stroke, using neuroimaging to study brain behavior relationships, with a recent focus on interactions of Alzheimer’s and silent stroke disease. She has earned numerous mentorship and research awards, and elected to the Royal Society of Canada in 2012. In 2015 she received the U of T Faculty of Medicine Dean’s Alumni Lifetime Achievement Award and was appointed an Officer to the Order of Canada for her contributions to Alzheimer’s disease, stroke and vascular dementia.
Sandra Black, MD, FRSC, OC, Oont
Affiliate Scientist, KITE (TRI)
dementia, apraxia, stroke recovery, neurorehabilitation, vascular cognitive impairment, cognitive neuroscience, neurodegenerative disorders, Lewy body dementia, frontotemporal dementia, neuroimaging biomarkers, cerebral small vessel disease, brain imaging analysis, Alzheimer disease, primary progressive aphasia (PPA)
Dr. Black's research foci include the following:
- Mild cognitive impairment and Alzheimer’s disease
- Vascular cognitive impairment and cerebral small vessel disease
- Parkinson’s disease, Lewy body spectrum disorder and frontotemporal dementia (behavioural variant, primary progressive aphasia)
- Apraxia and aphasia
- Stroke recovery
- Clinical trials in dementia and its prevention
- Neuroimaging biomarkers and brain-behaviour relationships
Cognition in Stroke Rehabilitation and Recovery Research: Consensus-Based Core Recommendations From the Second Stroke Recovery and Rehabilitation Roundtable.
Neurorehabil Neural Repair. 2019 Oct 29;:1545968319886444
Hippocampal segmentation for brains with extensive atrophy using three-dimensional convolutional neural networks.
Hum Brain Mapp. 2019 Oct 14;:
Neurology. 2019 Nov 05;93(19):e1807-e1819
Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease.
Eur Heart J Cardiovasc Imaging. 2019 Sep 30;:
First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound.
Nat Commun. 2019 Sep 26;10(1):4373
Neuroimage. 2019 Sep 23;204:116202
Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation.
J Geriatr Psychiatry Neurol. 2019 Sep 23;:891988719874118
Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto.
Int J Stroke. 2019 Sep 22;:1747493019871915
Ann Neurol. 2019 Sep 16;:
Increased Diameters of the Internal Cerebral Veins and the Basal Veins of Rosenthal Are Associated with White Matter Hyperintensity Volume.
AJNR Am J Neuroradiol. 2019 Oct;40(10):1712-1718
Affiliate Scientist, KITE (TRI)
Brill Chair in Neurology, University of Toronto, Sunnybrook Health Sciences Centre